Acquired Inhibitor to Factor VIII in a Nonhemophiliac Patient

An 81-year-old man was admitted to another hospital with multiple subcutaneous bruises. Laboratory values obtained there were as follows: hemoglobin 14.7 g/dL; activated partial thromboplastin time, 58 seconds (normal, 25 to 35 seconds); Lee White clotting time, 225 seconds; and platelet count, 588,000/mm3. At the time of transfer to this hospital, a review of the patient’s medical history showed that he had longstanding congestive cardiomyopathy and had taken digoxin and furosemide fot several years. Three months before admission, he was prescribed a quinidine preparation which was discontinued by his physician one week before his admission because of a maculopapular rash. There were scattered large ecchymoses over the neck, extremities, and sublingual area. There was a large hematoma over the left hip at the site of a previous intramuscular injection. The lungs were clear. The cardiovascular examination showed a left ventricular heave, a mitral regurgitant murmur, and an irregular pulse. The stool was hemoccult negative. Joint examination was normal. The laboratory values were as follows: hemoglobin, 10.0 g/dL; white blood count, 20.3/mm3; bleeding time, 5.0 minutes; platelet count, 259,000/mm3; partial thromboplastin time, 44 seconds; prothrombin time, 11.5 seconds (normal, 10.0 to 12.5 seconds); rheu-

[1]  E. Reece,et al.  Spontaneous factor XI inhibitors. Seven additional cases and a review of the literature. , 1984, Archives of internal medicine.

[2]  G. White,et al.  Factor VIII inhibitors: A clinical overview , 1982, American journal of hematology.

[3]  H. Roberts Hemophiliacs with inhibitors: therapeutic options. , 1981, The New England journal of medicine.

[4]  H. V. van Houwelingen,et al.  The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial. , 1981, The New England journal of medicine.

[5]  J. Lewis,et al.  Corticosteroid Therapy for Acquired F VIII:C Inhibitors , 1981, British journal of haematology.

[6]  K. Lechner,et al.  A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII , 1981, Thrombosis and Haemostasis.

[7]  A. Yoshioka,et al.  Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor. , 1981, Thrombosis Research.

[8]  D. Heath Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII , 1981 .

[9]  R. Stevens,et al.  Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors. , 1980, British medical journal.

[10]  S. Shapiro,et al.  Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. , 1980, The New England journal of medicine.

[11]  Shapiro Ss Antibodies to blood coagulation factors. , 1979 .

[12]  D. Green,et al.  Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide. , 1971, Blood.

[13]  H. Horowitz,et al.  Acquired hemophilia due to a circulating anticoagulant. Report of two cases, with review of the literature. , 1962, The American journal of medicine.

[14]  D. Jackson,et al.  CIRCULATING ANTICOAGULANTS: A STUDY OF 40 CASES AND A REVIEW OF THE LITERATURE , 1961, Medicine.

[15]  C. Abildgaard Hazards of prothrombin-complex concentrates in treatment of hemophilia. , 1981, The New England journal of medicine.

[16]  S. Shapiro Antibodies to blood coagulation factors. , 1979, Clinics in haematology.

[17]  E. Jaffe,et al.  A clinical study of the lupus anticoagulant. , 1976, Blood.

[18]  D. Green,et al.  A More Uniform Measurement of Factor VIII Inhibitors , 1975, Thrombosis and Haemostasis.

[19]  S. Rapaport,et al.  Acquired inhibitors of blood coagulation. , 1972, Progress in hemostasis and thrombosis.